Completed PHASE2 INTERVENTIONAL 5-arm NCT01490632

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of Baricitinib in Patients With Moderate-to-Severe Plaque Psoriasis

Sponsor: Eli Lilly and Company

Conditions Psoriasis Skin Diseases Skin Diseases, Papulosquamous

Interventions Baricitinib Placebo

Updated 10 times since 2017 Last updated: Sep 10, 2019 Started: Dec 31, 2011 Primary completion: Dec 31, 2012 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Psoriasis and Skin Diseases, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2
Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Oct 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Oct 2019 [monthly]

Completed PHASE2
Aug 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Aug 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eli Lilly and Company
Incyte Corporation

Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Alpharetta, United States , Arlington Heights, United States , Austin, United States , Bakersfield, United States , Carolina, Puerto Rico , Chiba, Japan , Dallas, United States , East Windsor, United States , Exton, United States and 25 more locations